Maze Therapeutics, Inc.
SEC CIK 1842295 · MAZE · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Coloma Jason V | Director · Chief Executive Officer | filed 2025 - 2026 |
| Homcy Charles J | Director | filed 2025 - 2026 |
| Scheller Richard H | Director | filed 2025 - 2026 |
| Spiegelman Daniel K | Director | filed 2025 - 2026 |
| Lim Jonathan E | Director | filed 2025 - 2026 |
| Hoppenot Herve | Director | filed 2025 - 2026 |
| Andrews Nancy C | Director | filed 2025 - 2026 |
| Kumar Neil | Director | filed 2026 - 2026 |
| Sohn Catherine A. | Director | filed 2025 - 2026 |
| Exter Neil | Director | filed 2025 - 2025 |
| Kathiresan Sekar | Director | filed 2025 - 2025 |
| Colowick Alan | Director | filed 2025 - 2025 |
| Tong Jeffrey K | Director | filed 2025 - 2025 |
| Brush James | Director | filed 2025 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bernstein Harold | President, R&D & CMO | filed 2025 - 2026 |
| Dandekar Atul | CSBO | filed 2025 - 2026 |
| Bachrodt Amy | SVP, Finance | filed 2025 - 2026 |
| Courtney Phillips | GC and Corp. Secretary | filed 2025 - 2026 |
| Tahir Misbah | Chief Financial Officer | filed 2025 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.